These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
30. [Tolerability and side-effects of bis-(hydroxy-2-ethylthio)-1,10-decane (BS 530) as compared with clofibrate in the therapy of hyperlipemia]. Colombo L; Monarca A; Goldberg D; Zanetta R Clin Ter; 1979 Oct; 91(2):155-71. PubMed ID: 540479 [No Abstract] [Full Text] [Related]
31. Clofibrate treatment of neonatal jaundice. Erkul I; Yavuz H; Ozel A Pediatrics; 1991 Dec; 88(6):1292-4. PubMed ID: 1956756 [No Abstract] [Full Text] [Related]
32. [Atypical muscular syndrome with myolysis during long-term treatment with fibrates]. Chauvin M; Zupan M; Brechenmacher C Arch Mal Coeur Vaiss; 1988 Jul; 81(7):921-3. PubMed ID: 3142389 [TBL] [Abstract][Full Text] [Related]
33. [Treatment of hyperlipemia with clofibrate in a case of nephrotic syndrome: secondary enzymatic and muscular alterations]. Fabre J; Denizot M; Giromini M; Micheli H J Urol Nephrol (Paris); 1973; 79(4):381-3. PubMed ID: 4720134 [No Abstract] [Full Text] [Related]
34. [Clofibrate in the treatment of diabetes mellitus]. Bornemisza P; Csögör I Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1978; 30(4):359-62. PubMed ID: 30153 [No Abstract] [Full Text] [Related]